Patients with chronic total occlusions (CTOs) had similar results whether they underwent PCIs or received optimal medical treatment, according to a prospective, open-label, randomized trial.

After reviewing data from a clinical trial, the FDA issued a letter to healthcare providers informing them that patients who received the Absorb bioresorbable vascular scaffold had an increased rate of major adverse cardiac events compared with patients treated with the Xience drug-eluting stent.

Patients who had ischemic and bleeding events 12 to 33 months after undergoing coronary stenting had an increased mortality risk, according to a post hoc analysis of a randomized study.

The U.S. Office of Special Counsel sent a letter to the White House last week noting that a Department of Veterans Affairs (VA) hospital in Illinois substantiated claims that a cardiologist made six years ago, CNN reports.

Since the beginning of the year, CMS has approved two facilities for performing carotid artery stenting for high risk patients.

Patients who have undergone heart surgery since 2012 may be at risk for developing an infection caused by the machine Stöckert 3T that could have been contaminated during manufacturing, reports News 12 New Jersey.

John Setaro, MD, a Connecticut cardiologist testified in court on March 9 that as many as five heart stents were unnecessarily implanted into a patient that led to dangerous complications.

Plaintiffs involved in 82 lawsuits alleging unnecessary cardiac procedures have reached settlements with the hospitals and cardiologist, the West Virginia Record reports.